Biliary Strictures Caused by Malignant Neoplasms

2

Review clinical trials related to Biliary Strictures Caused by Malignant Neoplasms. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

The HANAROSTENT® Multi-Hole™ Biliary Stent is Indicated for Use in the Palliative Treatment of Biliary Strictures Produced by Malignant Neoplasms and the Study is to Demonstrate Clinical Safety and Performance of the Multi-Hole™ Stent for the Palliative Treatment of Malignant Biliary Obstruction.

The objective of this study is to demonstrate clinical safety and performance of the HANAROSTENT® Multi-Hole™ Biliary Stent for the palliative treatment of malignant biliary obstruction.

Participants needed: 66
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Olympus Corporation of the AmericasUpdated: Jul 21, 2026
Eligibility criteria

Suspected or confirmed malignant non-hilar extrahepatic biliary obstruction incl...

Participation in another investigational study within 90 days prior to consent

Status: Not yet recruiting

Pre-cut Versus Intentional Double Guidewire for ERCP Cannulation: Prospective, Randomized Controlled Trial

Endoscopic retrograde cholangiopancreatography (ERCP) is an indispensable therapeutic procedure in the management of a wide spectrum of pancreaticobiliary disorders, including choledocholithiasis, benign and malignant biliary strictures, pancreatic ductal obstructions, and postoperative bile leaks. The procedure has revolutionized the management of these conditions, often obviating the need for surgery.Precut papillotomy and Double Guidewire Technique (DGT) are both salvage techniques used in ERCP when standard biliary cannulation fails. Precut (Needle-Knife Precut): An endoscopic incision made into the papilla to gain access to the bile duct when conventional methods fail. Intentional Double Guidewire Technique (DGT): A technique where a guidewire is intentionally placed into the pancreatic duct to act as a "guide" or anchor, straightening the biliary axis and allowing a second guidewire to be inserted into the bile duct.

Participants needed: 840
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Asian Institute of Gastroenterology, IndiaUpdated: Jan 12, 2026
Eligibility criteria

Valid indication for ERCP (benign or malignant obstruction). [+4]

Ampullary mass or tumor preventing standard cannulation view. [+3]